Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Feb;45(1):133-51.
doi: 10.1111/j.1475-6773.2009.01065.x. Epub 2009 Dec 4.

Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures

Anirban Basu  1 , Wesley Yin, G Caleb Alexander
Affiliations
Comparative Study

Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures

Anirban Basu et al. Health Serv Res. 2010 Feb.

Abstract

Objective: To examine the effect of Part D on 65-78-year-old noninstitutionalized dual eligibles' prescription utilization and expenditures.

Data source: Random sample of unique pharmacy customers of a national retail pharmacy chain who filled at least one prescription during both 2005 and 2006. For each subject, we obtained claims data for every prescription filled between January 1, 2005, and April 31, 2007.

Study design: Generalized estimating equations were used to examine the experience of a "treatment" group (dual eligibles between 65 and 78 years on January 1, 2005) with that of a "control" group (near-elderly patients with Medicaid coverage between 60 and 63 years on January 1, 2005) during the first 18 months after Part D implementation.

Principal findings: Expenditures for the treatment and control groups tracked each other closely in the pre-Part D period. Immediately following the implementation of Part D, expenditures for both groups decreased and then leveled off. There were no significant changes in trends in the dual eligibles' out-of-pocket expenditures, total monthly expenditures, pill-days, or total number of prescriptions due to Part D.

Conclusions: We find no evidence that Part D adversely affected pharmaceutical utilization or out-of-pocket expenditures of dual eligibles during the transition period, nor during the 16 months subsequent to Part D implementation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Observed and Predicted Time Trends in Outcomes for Dual Eligibles and the Control Group The corresponding factual and counterfactual trends post–Part D for the dual eligibles are also presented.
Figure 2
Figure 2
Observed and Predicted Time Trends in Outcomes for Dual Eligibles and the Control Group The corresponding factual and counterfactual trends post–Part D for the dual eligibles are also presented.
Figure 3
Figure 3
The Average Probability of Continuing a Medication (NDC-Code-Specific), Filled in the Pre–Part D Era, in the Post–Part D Stable Period
See this image and copyright information in PMC

References

    1. Bach PB, McClellan MB. The First Months of the Prescription-Drug Benefit—A CMS Update. New England Journal of Medicine. 2006;354:2312–4. - PubMed
    1. Bishop C, Thomas CP, Gilden D, Kubisiak J. Enrollment of Dually Eligible Beneficiaries in Medicare Part D Plans: Autoassignment and Choice. Academy Health Annual Research Meeting (Abstract), Chicago, IL.
    1. Crowley J, Ashner D, Elam L. State Medicaid Outpatient Prescription Drug Policies: Findings from a National Survey, 2005 Update. Menlo Park, CA: The Kaiser Commission on Medicaid and the Uninsured; 2005. [accessed on June 1, 2009] Available at http://www.kff.org/medicaid/7381.cfm.
    1. Fox K, Schofield L. The Pharmacy Coverage Safety Net: Variations in State Responses to Supplement Medicare Part D. Mimeo, University of Southern Maine.
    1. Frank RG, Newhouse JP. Should Drug Prices Be Negotiated under Part D of Medicare? And If So, How? Health Affairs. 2008;27(1):33–43. - PubMed

Publication types